AbCellera Biologics Inc 10-K for FY2021
AbCellera Biologics Inc. (ABCL)
10-K
2022-02-25
For: 2021-12-31
View Original
Added on
April 08, 2026
About this 10-K
AbCellera Biologics Inc filed this 10-K on February 25, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $375.2M
- up 60.9% from $233.16M a year earlier
- Net income
- $153.46M
- up 29.1% from net income of $118.92M a year earlier
- Diluted EPS
- $0.48
- up 6.7% from $0.45 a year earlier